Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Breast Neoplasms 3Endometrial Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1Thoracic Neoplasms 1Rectal Neoplasms 1Peritoneal Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Neoplasms by Site 1Neoplasms 1Lymphedema 1Lung Neoplasms 1Lung Diseases 1Hypoparathyroidism 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Carcinoma, Hepatocellular 1Adenoma 1

Interventions

Sorafenib 29Nivolumab 15pembrolizumab 12Radiosurgery 9Bevacizumab 9atezolizumab 7regorafenib 5Radiotherapy 5Fluorouracil 5Doxorubicin 5lenvatinib 4Sunitinib 4Oxaliplatin 4Ipilimumab 4Gemcitabine 4Ethiodized Oil 4Erlotinib Hydrochloride 4Capecitabine 4TLC 388 3Radiofrequency Ablation 3Leucovorin 3Everolimus 3Cisplatin 3Blood Specimen Collection 3toripalimab 2phosphomannopentaose sulfate 2durvalumab 2cediranib 2avelumab 2Tirapazamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Hepatocellular × Indocyanine Green × Clear all
NCT04258566 2026-02-02

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

National Institutes of Health Clinical Center (CC)

Phase NA Terminated
7 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡